Letter to the Editor Regarding “Promising strategies for the prevention of alcohol-related brain damage through optimised management of acute alcohol withdrawal: A focussed literature review”

Florentin M Liberopoulos EN Kei A , et al. (2011) Pleiotropic effects of nicotinic acid: Beyond high density lipoprotein cholesterol elevation. Current Vascular Pharmacology 9(4): 385–400.

Inwood M McGrehan F Lockman A (2025) The adherence to the guidelines for assessing and treating Wernicke’s encephalopathy in patients with alcohol withdrawal. Clinical Medicine 25(4): 100467.

Juel J Pareek M Langfrits CS , et al. (2013) Anaphylactic shock and cardiac arrest caused by thiamine infusion. BMJ Case Reports 2013: bcr2013009648.

NHSAAA Medicines (2025) NHSAAA medicines - Vitamin prophylaxis and treatment of Wernicke’s Encephalopathy. Available at: https://aaamedicines.org.uk/guidelines/central-nervous-system/vitamin-prophylaxis-and-treatment-of-wernicke-s-encephalopathy/ (accessed 20 December 2025).

Perez Nieto OR Wong A Lopez Fermin J , et al. (2021) Aiming for zero fluid accumulation: First, do no harm. Anaesthesiology Intensive Therapy 53(2): 162–178.

Quelch D Lingford-Hughes A John B , et al. (2025) Promising strategies for the prevention of alcohol-related brain damage through optimised management of acute alcohol withdrawal: A focussed literature review. Journal of Psychopharmacology 39(7): 652–666.

Thomson A Guerrini I Marshall EJ (2019) Incidence of adverse reactions to parenteral thiamine in the treatment of Wernicke’s Encephalopathy, and recommendations. Alcohol and Alcoholism 54(6): 609–614.